UROLOGICAL STUDIES OF FIBRINOLYTIC ENZYME SYSTEM

1962 ◽  
Vol 11 (3) ◽  
pp. 173-184 ◽  
Author(s):  
HAJIME TAMURA ◽  
HIDEYUKI TOFUKUJI ◽  
MASAMI OGAWA ◽  
NAMIO KONO
1970 ◽  
Vol 24 (01/02) ◽  
pp. 026-032 ◽  
Author(s):  
N. A Marsh

SummaryMolecular exclusion chromatography was performed on samples of urine from normal and aminonucleoside nephrotic rats. Normal urine contained 2 peaks of urokinase activity, one having a molecular weight of 22,000 and the other around 200,000. Nephrotic urine contained three peaks of activity with MW’s 126,000, 60,000 and 30,000. Plasma activator determined from euglobulin precipitate had a MW. in excess of 200,000. The results indicate that in the normal animal, plasma plasminogen activator does not escape into the urine in substantial quantities but under the conditions of extreme proteinuria there may be some loss through the kidney. The alteration in urokinase output in nephrotic animals indicates a greatly disordered renal fibrinolytic enzyme system.The findings of this study largely support the hypothesis that plasma plasminogen activator of renal origin and urinary plasminogen activator (urokinase) are different molecular species.


1966 ◽  
Vol 16 (01/02) ◽  
pp. 032-037 ◽  
Author(s):  
D Ogston ◽  
C. M Ogston ◽  
N. B Bennett

Summary1. The concentration of the major components of the fibrinolytic enzyme system was compared in venous and arterial blood samples from male subjects.2. The plasminogen activator concentration was higher in venous blood and the arterio-venous difference increased as its concentration rose, but the ratio of the arterial to venous level remained constant.3. No arterio-venous difference was found for anti-urokinase activity, antiplasmin, plasminogen and fibrinogen.4. It is concluded that venous blood determinations of the components of the fibrinolytic enzyme system reflect satisfactorily arterial blood levels.


Cancer ◽  
1959 ◽  
Vol 12 (4) ◽  
pp. 721-730 ◽  
Author(s):  
Louise Lang Phillips ◽  
Valija Skrodelis ◽  
Clement A. Furey

1978 ◽  
Vol 29 (4) ◽  
pp. 477-485 ◽  
Author(s):  
R. Zimmermann ◽  
W. Ehlers ◽  
E. Walter ◽  
A. Hoffrichter ◽  
P.D. Lang ◽  
...  

BMJ ◽  
1969 ◽  
Vol 4 (5680) ◽  
pp. 430-431
Author(s):  
J. Bonnar ◽  
J. F. Davidson ◽  
C. F. Pidgeon ◽  
G. P. McNicol ◽  
A. S. Douglas

1981 ◽  
Vol 26 (1_suppl) ◽  
pp. S59-S63 ◽  
Author(s):  
F. E. Preston

In a volunteer study stanozolol was given in a dosage of 5mg twice per day for six weeks. A variety of parameters in blood coagulation and fibrinolysis were measured. Significant stimulation of the fibrinolytic system was found in seven days and this was associated with a significant fall in the levels of fibrinogen and alpha 2-macroglobulin. No major side effects were observed.


Sign in / Sign up

Export Citation Format

Share Document